BSc, MSc, PhD
I joined the Translational Epidemiology Unit (TEU) in 2021 to work as a senior epidemiologist. My main area of interest is investigating risk factors for dementia, with a particular focus on research that produces translatable findings with a public health benefit. This includes identifying modifiable factors that can be potentially targeted for dementia prevention.
I am also involved in research which addresses similar questions for non-dementia outcomes, in particular cancer, cardiovascular disease and other common chronic diseases.
I primarily use the UK Biobank dataset, a population-based cohort of half a million participants with a diversity of phenotypic and genetic data measured. I am also interested in using other cohorts to either replicate or complement analyses conducted using UK Biobank.
I am a module lead for the Principles of Epidemiology module as part of the MSc in Global Health Science and Epidemiology.
Before joining the TEU, I worked as an epidemiologist for the Nuffield Department of Population Health (NDPH)-based UK Biobank scientific team between 2014-2021. Prior to joining NDPH, I completed a PhD at the University of Exeter on hormonal risk factors for late-onset dementia.
Speech‐in‐noise hearing impairment is associated with an increased risk of incident dementia in 82,039 UK Biobank participants
Stevenson JS. et al, (2021), Alzheimer's & Dementia
Human cytomegalovirus and risk of incident cardiovascular disease in UK Biobank
Hamilton E. et al, (2021), The Journal of Infectious Diseases
United Kingdom Biobank (UK Biobank): JACC Focus Seminar 6/8.
Caleyachetty R. et al, (2021), J Am Coll Cardiol, 78, 56 - 65
United Kingdom Biobank (UK Biobank)
Caleyachetty R. et al, (2021), Journal of the American College of Cardiology, 78, 56 - 65
Taking it to the bank: the ethical management of individual findings arising in secondary research.
Graham M. et al, (2021), J Med Ethics